The RNA Society announced that its 2019 Lifetime Achievement Award goes to Adrian Krainer (Cold Spring Harbor Laboratory). Adrian Krainer and his co-workers made seminal discoveries in the field of alternative splicing. Their contributions were essential for the development of the drug Spinraza for the treatment of patients with SMA. This antisense oligonucleotide drug changes the splicing pattern of the SMN2 pre-mRNA and thereby leads to elevated levels of functional SMN protein.
The award will be presented to him at the RNA Society's Annual meeting taking place from June 11 - 16, 2019 in Krakow, Poland.
The NCCR RNA & Disease congratulates its Scientific Advisory Board Member!